SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6fyl'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IEP_A_STIA201_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
GLY A 247
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 1.26A 1iepA-6fylA:
21.6		 1iepA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OPJ_B_STIB4_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.56A 1opjB-6fylA:
21.4		 1opjB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6K_A_ACTA860_0
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 TRP A 358
VAL A 352
ALA A 349
SER A 366
 None
 0.94A 1p6kA-6fylA:
undetectable		 1p6kA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6K_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.46A 1p6kA-6fylA:
undetectable
1p6kB-6fylA:
undetectable		 1p6kA-6fylA:
undetectable
1p6kB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		9 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
GLY A 247
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 0.99A 1t46A-6fylA:
22.4		 1t46A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		9 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
VAL A 227
GLY A 247
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 0.83A 1t46A-6fylA:
22.4		 1t46A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_A_BAXA1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 ALA A 191
GLU A 208
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.52A 1uwhA-6fylA:
22.6		 1uwhA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_B_BAXB1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
LYS A 193
GLU A 208
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 0.59A 1uwhB-6fylA:
22.4		 1uwhB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWJ_A_BAXA1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 VAL A 177
ALA A 191
GLU A 208
LEU A 281
HIS A 288
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
 0.56A 1uwjA-6fylA:
22.2		 1uwjA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A1O_A_CAMA1422_0
(CYTOCHROME P450-CAM)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 8 PHE A 453
THR A 443
GLY A 377
VAL A 267
 None
 0.93A 2a1oA-6fylA:
undetectable		 2a1oA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EUF_B_LQQB401_1
(CELL DIVISION
PROTEIN KINASE 6)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
LYS A 193
VAL A 227
PHE A 243
ASN A 295
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
None
3NG  A 501 (-3.5A)
None
None
3NG  A 501 (-4.5A)
 0.86A 2eufB-6fylA:
30.4		 2eufB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.54A 2hyyB-6fylA:
22.1		 2hyyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
VAL A 211
VAL A 227
ILE A 241
 3NG  A 501 (-3.9A)
None
None
None
 0.69A 2hyyB-6fylA:
22.1		 2hyyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_C_STIC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.65A 2hyyC-6fylA:
22.2		 2hyyC-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_D_STID600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
ILE A 215
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.23A 2hyyD-6fylA:
16.2		 2hyyD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_C_B49C1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 10 VAL A 177
ALA A 191
PHE A 243
LEU A 245
ASP A 252
LEU A 297
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
 0.65A 2y7jC-6fylA:
28.1		 2y7jC-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_D_B49D1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 10 VAL A 177
ALA A 191
PHE A 243
LEU A 245
ASP A 252
LEU A 297
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
 0.62A 2y7jD-6fylA:
28.2		 2y7jD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_A_NILA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 10 LEU A 169
VAL A 177
VAL A 227
ILE A 241
VAL A 325
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
None
None
None
3NG  A 501 (-4.5A)
 0.80A 3cs9A-6fylA:
21.7		 3cs9A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 9 LEU A 169
VAL A 177
LYS A 193
ILE A 241
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
None
None
 0.89A 3cs9B-6fylA:
17.1		 3cs9B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 9 LEU A 169
VAL A 177
VAL A 227
ILE A 241
LEU A 297
VAL A 325
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
None
None
None
None
 0.77A 3cs9B-6fylA:
17.1		 3cs9B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_C_NILC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 9 LEU A 169
VAL A 177
VAL A 227
ILE A 241
VAL A 325
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
None
None
None
 0.52A 3cs9C-6fylA:
21.5		 3cs9C-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GP0_A_NILA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 11)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 VAL A 177
ALA A 191
GLU A 208
LEU A 212
HIS A 288
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 1.08A 3gp0A-6fylA:
25.8		 3gp0A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GVU_A_STIA1001_1
(TYROSINE-PROTEIN
KINASE ABL2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
VAL A 227
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 0.98A 3gvuA-6fylA:
22.0		 3gvuA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEC_A_STIA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 ALA A 191
LYS A 193
GLU A 208
LEU A 212
LEU A 245
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 ( 4.7A)
 0.55A 3hecA-6fylA:
25.2		 3hecA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEG_A_BAXA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
 0.81A 3hegA-6fylA:
24.7		 3hegA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 ALA A 191
GLU A 208
ILE A 215
VAL A 227
HIS A 288
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.67A 3ik3A-6fylA:
16.2		 3ik3A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.57A 3ik3A-6fylA:
16.2		 3ik3A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
GLU A 208
ILE A 215
VAL A 227
HIS A 288
LEU A 297
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
None
 0.79A 3ik3B-6fylA:
21.5		 3ik3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.57A 3ik3B-6fylA:
21.6		 3ik3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.54A 3k5vA-6fylA:
21.4		 3k5vA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
VAL A 211
VAL A 227
ILE A 241
 3NG  A 501 (-3.9A)
None
None
None
 0.67A 3k5vA-6fylA:
21.4		 3k5vA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.59A 3k5vB-6fylA:
21.2		 3k5vB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
VAL A 211
VAL A 227
ILE A 241
 3NG  A 501 (-3.9A)
None
None
None
 0.78A 3k5vB-6fylA:
21.2		 3k5vB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MS9_A_STIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
ILE A 215
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 1.21A 3ms9A-6fylA:
16.2		 3ms9A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_A_STIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
ILE A 215
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 1.20A 3mssA-6fylA:
2.3		 3mssA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_C_STIC1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
ILE A 215
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
 1.05A 3mssC-6fylA:
21.6		 3mssC-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 VAL A 177
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
None
None
 0.55A 3mssD-6fylA:
21.7		 3mssD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 VAL A 177
VAL A 211
VAL A 227
ILE A 241
 3NG  A 501 ( 4.4A)
None
None
None
 0.75A 3mssD-6fylA:
21.7		 3mssD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_B_1N1B1000_1
(P38A)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 GLY A 170
VAL A 177
ALA A 191
LYS A 193
LEU A 212
GLY A 247
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
 0.72A 3ohtB-6fylA:
5.0		 3ohtB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 ALA A 191
GLU A 208
ILE A 215
VAL A 227
GLY A 247
HIS A 288
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
None
3NG  A 501 (-4.5A)
 1.22A 3oxzA-6fylA:
21.6		 3oxzA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 9 LEU A 169
LYS A 193
VAL A 211
ILE A 241
LEU A 246
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
3NG  A 501 (-4.2A)
 1.04A 3oxzA-6fylA:
21.7		 3oxzA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 9 LEU A 169
LYS A 193
VAL A 211
ILE A 241
LEU A 297
VAL A 325
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
None
None
 0.96A 3oxzA-6fylA:
21.7		 3oxzA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P4W_D_DSFD319_1
(GLR4197 PROTEIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 10 ILE A 296
VAL A 278
TYR A 347
ILE A 370
ILE A 367
 None
 1.20A 3p4wD-6fylA:
undetectable		 3p4wD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P4W_E_DSFE319_1
(GLR4197 PROTEIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 10 ILE A 296
VAL A 278
TYR A 347
ILE A 370
ILE A 367
 None
 1.20A 3p4wE-6fylA:
undetectable		 3p4wE-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_B_STIB4_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
ILE A 215
VAL A 227
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.83A 3pyyB-6fylA:
21.5		 3pyyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_B_STIB4_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
VAL A 227
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 0.94A 3pyyB-6fylA:
21.5		 3pyyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RGF_A_BAXA465_1
(CYCLIN-DEPENDENT
KINASE 8)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
LEU A 212
PHE A 243
LEU A 281
HIS A 288
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 (-3.5A)
None
None
 0.62A 3rgfA-6fylA:
6.9		 3rgfA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UE4_A_DB8A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
ALA A 191
LYS A 193
GLU A 208
ILE A 241
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 1.23A 3ue4A-6fylA:
24.4		 3ue4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.45A 3ufrA-6fylA:
undetectable
3ufrB-6fylA:
undetectable		 3ufrA-6fylA:
undetectable
3ufrB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFS_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.45A 3ufsA-6fylA:
undetectable
3ufsB-6fylA:
undetectable		 3ufsA-6fylA:
undetectable
3ufsB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
LEU A 212
GLY A 247
LEU A 281
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.72A 3wzeA-6fylA:
22.2		 3wzeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.67A 3wzeA-6fylA:
22.2		 3wzeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
LEU A 212
GLY A 247
LEU A 281
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
None
 0.71A 3wzeA-6fylA:
22.2		 3wzeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
None
 0.60A 3wzeA-6fylA:
22.2		 3wzeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AG8_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		8 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
VAL A 227
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 1.07A 4ag8A-6fylA:
22.1		 4ag8A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AGC_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
LEU A 212
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
None
 1.04A 4agcA-6fylA:
21.7		 4agcA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		9 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
GLY A 247
LEU A 281
HIS A 288
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
None
 0.87A 4asdA-6fylA:
22.0		 4asdA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C39_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.44A 4c39A-6fylA:
undetectable
4c39B-6fylA:
undetectable		 4c39A-6fylA:
undetectable
4c39B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C39_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.40A 4c39A-6fylA:
undetectable
4c39B-6fylA:
undetectable		 4c39A-6fylA:
undetectable
4c39B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 ALA A 191
LYS A 193
GLU A 208
ILE A 241
HIS A 288
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 0.95A 4c8bA-6fylA:
22.1		 4c8bA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 ALA A 191
LYS A 193
GLU A 208
LEU A 212
ILE A 241
HIS A 288
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.02A 4c8bA-6fylA:
22.1		 4c8bA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.39A 4ctpA-6fylA:
undetectable
4ctpB-6fylA:
undetectable		 4ctpA-6fylA:
undetectable
4ctpB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.35A 4ctqA-6fylA:
undetectable
4ctqB-6fylA:
undetectable		 4ctqA-6fylA:
undetectable
4ctqB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.38A 4cx6A-6fylA:
undetectable
4cx6B-6fylA:
undetectable		 4cx6A-6fylA:
undetectable
4cx6B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I41_A_MIXA500_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
ASP A 290
LYS A 292
ASN A 295
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
None
None
None
None
3NG  A 501 (-4.5A)
 0.64A 4i41A-6fylA:
25.4		 4i41A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSF_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.42A 4jsfA-6fylA:
undetectable
4jsfB-6fylA:
undetectable		 4jsfA-6fylA:
undetectable
4jsfB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSG_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.41A 4jsgA-6fylA:
undetectable
4jsgB-6fylA:
undetectable		 4jsgA-6fylA:
undetectable
4jsgB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5G_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.42A 4k5gA-6fylA:
undetectable
4k5gB-6fylA:
undetectable		 4k5gA-6fylA:
undetectable
4k5gB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.44A 4luxA-6fylA:
undetectable
4luxB-6fylA:
undetectable		 4luxA-6fylA:
undetectable
4luxB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWV_A_BCZA513_1
(NEURAMINIDASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		3 / 3 ARG A 395
GLU A 433
ARG A 440
 None
 0.82A 4mwvA-6fylA:
undetectable		 4mwvA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O0W_A_ADNA501_1
(AURORA KINASE A)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 6 LEU A 169
GLY A 170
VAL A 177
ALA A 191
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
None
 0.39A 4o0wA-6fylA:
25.4		 4o0wA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OAE_A_CLMA207_0
(GNAT SUPERFAMILY
ACETYLTRANSFERASE
PA4794)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 PHE A 414
ARG A 387
ALA A 391
ALA A 427
GLY A 428
 None
 0.93A 4oaeA-6fylA:
undetectable		 4oaeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OTI_A_MI1A1001_1
(SERINE/THREONINE-PRO
TEIN KINASE N1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		8 / 12 LEU A 169
GLY A 170
GLY A 172
GLY A 175
VAL A 177
ALA A 191
LYS A 193
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.5A)
None
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
 0.52A 4otiA-6fylA:
21.2		 4otiA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OTI_A_MI1A1001_1
(SERINE/THREONINE-PRO
TEIN KINASE N1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
GLY A 170
GLY A 175
VAL A 177
ALA A 191
LYS A 193
VAL A 227
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
None
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
 0.62A 4otiA-6fylA:
21.2		 4otiA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMN_A_DB8A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
LYS A 193
GLU A 208
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 0.75A 4qmnA-6fylA:
26.6		 4qmnA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R7I_A_STIA1001_1
(MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 (-4.5A)
 0.74A 4r7iA-6fylA:
22.0		 4r7iA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TYJ_A_0LIA801_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 4)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
GLU A 208
ILE A 215
HIS A 288
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.19A 4tyjA-6fylA:
22.3		 4tyjA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U0I_A_0LIA1001_2
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR
KIT,MAST/STEM CELL
GROWTH FACTOR
RECEPTOR KIT)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 ALA A 191
LYS A 193
LEU A 212
GLY A 247
HIS A 288
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
None
None
3NG  A 501 (-4.5A)
 1.15A 4u0iA-6fylA:
22.4		 4u0iA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UGZ_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.37A 4ugzA-6fylA:
undetectable
4ugzB-6fylA:
undetectable		 4ugzA-6fylA:
undetectable
4ugzB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.39A 4uh3A-6fylA:
undetectable
4uh3B-6fylA:
undetectable		 4uh3A-6fylA:
undetectable
4uh3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH5_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.36A 4uh5A-6fylA:
undetectable
4uh5B-6fylA:
undetectable		 4uh5A-6fylA:
undetectable
4uh5B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.39A 4uh6A-6fylA:
undetectable
4uh6B-6fylA:
undetectable		 4uh6A-6fylA:
undetectable
4uh6B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.31A 4uh6A-6fylA:
undetectable
4uh6B-6fylA:
undetectable		 4uh6A-6fylA:
undetectable
4uh6B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3W_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.40A 4v3wA-6fylA:
0.9
4v3wB-6fylA:
undetectable		 4v3wA-6fylA:
undetectable
4v3wB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WKQ_A_IREA1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 LEU A 169
ALA A 191
LYS A 193
GLU A 208
LEU A 245
ASP A 252
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
 0.53A 4wkqA-6fylA:
24.0		 4wkqA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WKQ_A_IREA1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
ALA A 191
LYS A 193
GLU A 208
LEU A 245
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
None
 1.10A 4wkqA-6fylA:
24.0		 4wkqA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 ALA A 191
LYS A 193
LEU A 212
ASP A 327
PHE A 328
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
3NG  A 501 (-4.5A)
None
 0.93A 4xv2B-6fylA:
22.2		 4xv2B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.43A 5ad4A-6fylA:
undetectable
5ad4B-6fylA:
undetectable		 5ad4A-6fylA:
undetectable
5ad4B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.41A 5ad4A-6fylA:
undetectable
5ad4B-6fylA:
undetectable		 5ad4A-6fylA:
undetectable
5ad4B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.33A 5ad5A-6fylA:
undetectable
5ad5B-6fylA:
undetectable		 5ad5A-6fylA:
undetectable
5ad5B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.28A 5ad6A-6fylA:
undetectable
5ad6B-6fylA:
undetectable		 5ad6A-6fylA:
undetectable
5ad6B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.34A 5adaA-6fylA:
undetectable
5adaB-6fylA:
undetectable		 5adaA-6fylA:
undetectable
5adaB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.39A 5adaA-6fylA:
undetectable
5adaB-6fylA:
undetectable		 5adaA-6fylA:
undetectable
5adaB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADG_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.35A 5adgA-6fylA:
undetectable
5adgB-6fylA:
undetectable		 5adgA-6fylA:
undetectable
5adgB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADI_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.35A 5adiA-6fylA:
undetectable
5adiB-6fylA:
undetectable		 5adiA-6fylA:
undetectable
5adiB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 VAL A 177
ALA A 191
LYS A 193
LEU A 212
PHE A 328
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
 0.82A 5cswA-6fylA:
21.4		 5cswA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 VAL A 177
ALA A 191
LYS A 193
LEU A 212
PHE A 328
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
 0.84A 5cswB-6fylA:
21.4		 5cswB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.31A 5fvtA-6fylA:
undetectable
5fvtB-6fylA:
undetectable		 5fvtA-6fylA:
undetectable
5fvtB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVU_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.39A 5fvuA-6fylA:
undetectable
5fvuB-6fylA:
undetectable		 5fvuA-6fylA:
undetectable
5fvuB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.44A 5fvvA-6fylA:
undetectable
5fvvB-6fylA:
undetectable		 5fvvA-6fylA:
undetectable
5fvvB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVV_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.44A 5fvvA-6fylA:
undetectable
5fvvB-6fylA:
undetectable		 5fvvA-6fylA:
undetectable
5fvvB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVW_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.36A 5fvwA-6fylA:
undetectable
5fvwB-6fylA:
undetectable		 5fvwA-6fylA:
undetectable
5fvwB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVW_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.40A 5fvwA-6fylA:
undetectable
5fvwB-6fylA:
undetectable		 5fvwA-6fylA:
undetectable
5fvwB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVX_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.36A 5fvxA-6fylA:
undetectable
5fvxB-6fylA:
undetectable		 5fvxA-6fylA:
undetectable
5fvxB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FW0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.28A 5fw0A-6fylA:
undetectable
5fw0B-6fylA:
undetectable		 5fw0A-6fylA:
undetectable
5fw0B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0N_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.44A 5g0nA-6fylA:
undetectable
5g0nB-6fylA:
undetectable		 5g0nA-6fylA:
undetectable
5g0nB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0N_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.33A 5g0nA-6fylA:
undetectable
5g0nB-6fylA:
undetectable		 5g0nA-6fylA:
undetectable
5g0nB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HI2_A_BAXA801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
LYS A 193
GLU A 208
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 0.63A 5hi2A-6fylA:
22.6		 5hi2A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IZJ_G_AZ1G2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAR-DAR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 GLY A 170
GLY A 172
VAL A 177
LYS A 193
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
 0.46A 5izjA-6fylA:
25.1		 5izjA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J5X_B_AZ1B2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAL-DAR-DAR-
DAR-DAR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 GLY A 170
GLY A 172
VAL A 177
LYS A 193
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
 0.34A 5j5xA-6fylA:
25.1		 5j5xA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_H_ADNH401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 9 GLY A 170
VAL A 177
ALA A 191
LEU A 245
LEU A 297
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.7A)
None
 1.07A 5lw1H-6fylA:
17.4		 5lw1H-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 10 LEU A 169
VAL A 177
LYS A 193
GLU A 208
ILE A 241
GLY A 247
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
 0.67A 5mo4A-6fylA:
19.0		 5mo4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OWR_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 8 ALA A 191
GLU A 208
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 (-4.5A)
 0.66A 5owrA-6fylA:
14.9		 5owrA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.32A 5untA-6fylA:
undetectable
5untB-6fylA:
undetectable		 5untA-6fylA:
undetectable
5untB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNU_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.40A 5unuA-6fylA:
undetectable
5unuB-6fylA:
undetectable		 5unuA-6fylA:
undetectable
5unuB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.30A 5unuA-6fylA:
undetectable
5unuB-6fylA:
undetectable		 5unuA-6fylA:
undetectable
5unuB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.39A 5unwA-6fylA:
undetectable
5unwB-6fylA:
undetectable		 5unwA-6fylA:
undetectable
5unwB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNY_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.42A 5unyA-6fylA:
undetectable
5unyB-6fylA:
undetectable		 5unyA-6fylA:
undetectable
5unyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.42A 5unyA-6fylA:
undetectable
5unyB-6fylA:
undetectable		 5unyA-6fylA:
undetectable
5unyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.40A 5uo1A-6fylA:
undetectable
5uo1B-6fylA:
undetectable		 5uo1A-6fylA:
undetectable
5uo1B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.33A 5uo1A-6fylA:
undetectable
5uo1B-6fylA:
undetectable		 5uo1A-6fylA:
undetectable
5uo1B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.32A 5uo3A-6fylA:
undetectable
5uo3B-6fylA:
undetectable		 5uo3A-6fylA:
undetectable
5uo3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO3_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.32A 5uo3A-6fylA:
undetectable
5uo3B-6fylA:
undetectable		 5uo3A-6fylA:
undetectable
5uo3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.34A 5uo4A-6fylA:
undetectable
5uo4B-6fylA:
undetectable		 5uo4A-6fylA:
undetectable
5uo4B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO5_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.33A 5uo5A-6fylA:
undetectable
5uo5B-6fylA:
undetectable		 5uo5A-6fylA:
undetectable
5uo5B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO6_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.33A 5uo6A-6fylA:
undetectable
5uo6B-6fylA:
undetectable		 5uo6A-6fylA:
undetectable
5uo6B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO7_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 8 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.32A 5uo7A-6fylA:
undetectable
5uo7B-6fylA:
undetectable		 5uo7A-6fylA:
undetectable
5uo7B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO7_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.29A 5uo7A-6fylA:
undetectable
5uo7B-6fylA:
undetectable		 5uo7A-6fylA:
undetectable
5uo7B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.40A 5vuiA-6fylA:
undetectable
5vuiB-6fylA:
undetectable		 5vuiA-6fylA:
undetectable
5vuiB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.28A 5vuiA-6fylA:
undetectable
5vuiB-6fylA:
undetectable		 5vuiA-6fylA:
undetectable
5vuiB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUV_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.35A 5vuvA-6fylA:
undetectable
5vuvB-6fylA:
undetectable		 5vuvA-6fylA:
undetectable
5vuvB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV3_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.35A 5vv3A-6fylA:
undetectable
5vv3B-6fylA:
undetectable		 5vv3A-6fylA:
undetectable
5vv3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.34A 5vv4A-6fylA:
undetectable
5vv4B-6fylA:
undetectable		 5vv4A-6fylA:
undetectable
5vv4B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WWS_B_SAMB501_0
(PUTATIVE
METHYLTRANSFERASE
NSUN6)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 GLY A 172
ILE A 241
LYS A 193
ASP A 234
GLY A 237
 3NG  A 501 ( 4.5A)
None
3NG  A 501 (-3.0A)
None
None
 1.04A 5wwsB-6fylA:
undetectable		 5wwsB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDH_C_DAHC60_1
(PUTATIVE CYTOCHROME
C)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 HIS A 335
ASN A 284
VAL A 211
LEU A 207
 None
 1.29A 5xdhA-6fylA:
undetectable
5xdhC-6fylA:
undetectable		 5xdhA-6fylA:
undetectable
5xdhC-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XV7_A_EMHA705_1
(SERINE-ARGININE (SR)
PROTEIN KINASE 1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 LEU A 169
GLY A 170
VAL A 177
ALA A 191
PHE A 243
GLY A 247
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.5A)
None
 0.62A 5xv7A-6fylA:
37.1		 5xv7A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		8 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 245
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
None
 0.79A 5y7zA-6fylA:
25.3		 5y7zA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_B_IREB401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		8 / 12 LEU A 169
ALA A 191
LYS A 193
GLU A 208
LEU A 245
GLY A 247
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
None
3NG  A 501 (-4.5A)
 0.94A 5y7zB-6fylA:
16.7		 5y7zB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y80_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		9 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 245
GLY A 247
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
None
3NG  A 501 (-4.5A)
 0.92A 5y80A-6fylA:
24.3		 5y80A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y9M_X_NIOX401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 8 LEU A 169
VAL A 177
LYS A 193
PHE A 243
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
3NG  A 501 (-3.5A)
 0.71A 5y9mX-6fylA:
27.7		 5y9mX-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YF9_B_NIOB401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 VAL A 177
LYS A 193
PHE A 243
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
3NG  A 501 (-3.5A)
3NG  A 501 (-4.5A)
 0.83A 5yf9B-6fylA:
27.6		 5yf9B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUR_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.34A 6aurA-6fylA:
undetectable
6aurB-6fylA:
undetectable		 6aurA-6fylA:
undetectable
6aurB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.32A 6aurA-6fylA:
undetectable
6aurB-6fylA:
undetectable		 6aurA-6fylA:
undetectable
6aurB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.32A 6autA-6fylA:
undetectable
6autB-6fylA:
undetectable		 6autA-6fylA:
undetectable
6autB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUV_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.42A 6auvA-6fylA:
undetectable
6auvB-6fylA:
undetectable		 6auvA-6fylA:
undetectable
6auvB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.36A 6auyA-6fylA:
undetectable
6auyB-6fylA:
0.9		 6auyA-6fylA:
undetectable
6auyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUZ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.37A 6auzA-6fylA:
undetectable
6auzB-6fylA:
undetectable		 6auzA-6fylA:
undetectable
6auzB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.35A 6auzA-6fylA:
undetectable
6auzB-6fylA:
undetectable		 6auzA-6fylA:
undetectable
6auzB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV0_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.34A 6av0A-6fylA:
undetectable
6av0B-6fylA:
undetectable		 6av0A-6fylA:
undetectable
6av0B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.38A 6av1A-6fylA:
undetectable
6av1B-6fylA:
undetectable		 6av1A-6fylA:
undetectable
6av1B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.43A 6av1A-6fylA:
undetectable
6av1B-6fylA:
undetectable		 6av1A-6fylA:
undetectable
6av1B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV2_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.35A 6av2A-6fylA:
undetectable
6av2B-6fylA:
undetectable		 6av2A-6fylA:
undetectable
6av2B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV3_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.37A 6av3A-6fylA:
undetectable
6av3B-6fylA:
undetectable		 6av3A-6fylA:
undetectable
6av3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.34A 6av4A-6fylA:
undetectable
6av4B-6fylA:
undetectable		 6av4A-6fylA:
undetectable
6av4B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.37A 6av5A-6fylA:
undetectable
6av5B-6fylA:
undetectable		 6av5A-6fylA:
undetectable
6av5B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV5_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.35A 6av5A-6fylA:
undetectable
6av5B-6fylA:
undetectable		 6av5A-6fylA:
undetectable
6av5B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CIC_A_H4BA802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.39A 6cicA-6fylA:
undetectable
6cicB-6fylA:
undetectable		 6cicA-6fylA:
undetectable
6cicB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CIC_B_H4BB802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.37A 6cicA-6fylA:
undetectable
6cicB-6fylA:
undetectable		 6cicA-6fylA:
undetectable
6cicB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CID_A_H4BA802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 MET A 393
VAL A 431
TRP A 421
GLU A 394
 None
 1.35A 6cidA-6fylA:
undetectable
6cidB-6fylA:
undetectable		 6cidA-6fylA:
undetectable
6cidB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CID_B_H4BB803_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 TRP A 421
GLU A 394
MET A 393
VAL A 431
 None
 1.36A 6cidA-6fylA:
undetectable
6cidB-6fylA:
undetectable		 6cidA-6fylA:
undetectable
6cidB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
ILE A 215
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.20A 6hd4A-6fylA:
7.3		 6hd4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
VAL A 227
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.03A 6hd4A-6fylA:
7.3		 6hd4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
LYS A 193
GLU A 208
ILE A 215
ILE A 241
LEU A 297
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 1.01A 6hd4A-6fylA:
7.3		 6hd4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_B_STIB602_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
ILE A 215
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.18A 6hd4B-6fylA:
21.2		 6hd4B-6fylA:
undetectable